Identification of toxigenic Clostridium difficile by counterimmunoelectrophoresis.

Enzyme-linked immunosorbent assay for Clostridium difficile toxin A. J Clin Microbiol (1983) 3.40

Identification of toxigenic Clostridium difficile by the polymerase chain reaction. J Clin Microbiol (1991) 2.51

Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A. J Clin Microbiol (1985) 2.46

Rapid detection of Clostridium difficile toxin in human feces. J Clin Microbiol (1980) 2.33

Clostridium difficile: clinical disease and diagnosis. Clin Microbiol Rev (1993) 2.19

Evaluation of the usefulness of counterimmunoelectrophoresis for diagnosis of Clostridium difficile-associated colitis in clinical specimens. J Clin Microbiol (1983) 1.78

Problems associated with counterimmunoelectrophoresis assays for detecting Clostridium difficile toxin. J Clin Microbiol (1982) 1.75

Detection of Clostridium difficile toxin by counterimmunoelectrophoresis: a note of caution. J Clin Microbiol (1981) 1.58

Latex agglutination test for detection of Clostridium difficile toxin in stool samples. J Clin Microbiol (1984) 1.39

Evaluation of a latex agglutination test for Clostridium difficile in two nursing home outbreaks. J Clin Microbiol (1989) 1.20

Isolation of Clostridium difficile from hospitalized patients without antibiotic-associated diarrhea or colitis. J Clin Microbiol (1982) 1.00

Detection of Clostridium difficile in faeces by direct gas liquid chromatography. J Clin Pathol (1984) 0.97

Fluorescent-antibody test for detection of Clostridium difficile in stool specimens. J Clin Microbiol (1982) 0.96

Technique for measuring 50% end points in cytotoxicity assays for Clostridium difficile toxins. J Clin Pathol (1986) 0.80

Criteria for detection of Clostridium difficile toxin production by counterimmunoelectrophoresis. J Clin Microbiol (1984) 0.80

Toxigenic Clostridium perfringens from a parvovirus-infected dog. J Clin Microbiol (1981) 0.75

Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol (1979) 12.54

Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet (1978) 11.99

Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin. Lancet (1977) 8.77

Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br Med J (1978) 8.47

Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis (1977) 7.68

Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology (1978) 5.91

Aetiology of antimicrobial-agent-associated colitis. Lancet (1978) 5.91

Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infect Immun (1978) 3.93

Colitis induced by Clostridium difficile. Rev Infect Dis (1980) 3.15

Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxins. Infect Immun (1978) 2.39

Urease-negative strains of Clostridium sordellii. Can J Microbiol (1976) 1.07

SEROLOGICAL RELATIONSHIP BETWEEN CLOSTRIDIUM BIFERMENTANS AND CLOSTRIDIUM SORDELLII BASED UPON SOLUBLE ANTIGENS. J Bacteriol (1963) 1.00

Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study. Antimicrob Agents Chemother (1975) 17.12

Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. J Clin Microbiol (1981) 8.49

Comparative study of the efficacy of seven paper-reagent strips and conventional biochemical tests in identifying gram-negative organisms. Appl Microbiol (1969) 8.23

Comparison of micro-ID, API 20E, and conventional media systems in identification of Enterobacteriaceae. J Clin Microbiol (1978) 7.65

Comparison of macroscopic examination, routine gram stains, and routine subcultures in the initial detection of positive blood cultures. Appl Microbiol (1974) 7.33

Effect of aerobic and anaerobic atmospheres on isolation of organisms from blood cultures. J Clin Microbiol (1975) 5.23

Rapid extraction method with pronase B for grouping beta-hemolytic streptococci. Appl Microbiol (1972) 4.61

A newly recognized fastidious gram-negative pathogen as a cause of fever and bacteremia. N Engl J Med (1990) 4.46

Evaluation of the Bauer-Kirby-Sherris-Turck single-disc diffusion method of antibiotic susceptibility testing. Antimicrob Agents Chemother (Bethesda) (1969) 4.12

In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound. Antimicrob Agents Chemother (1983) 4.00

Rapid semiautomated screening and processing of urine specimens. J Clin Microbiol (1980) 3.01

Characterization of ornithine decarboxylase-positive, nonmotile strains of the Klebsiella-Enterobacter group. Appl Microbiol (1969) 2.99

Colonization and infection with Pseudomonas cepacia. J Infect Dis (1972) 2.91

Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus. J Clin Microbiol (1993) 2.85

Microwave oven irradiation as a method for bacterial decontamination in a clinical microbiology laboratory. J Clin Microbiol (1977) 2.76

Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism. N Engl J Med (1995) 2.74

Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol (1987) 2.59

Evaluation of the PathoTec "Rapid I-D System". Appl Microbiol (1973) 2.54

Rapid gentamicin bioassay using a multiple-antibiotic-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother (1973) 2.51

Evaluation of an adenosine 5'-triphosphate assay as a screening method to detect significant bacteriuria. J Clin Microbiol (1976) 2.48

Rapid identification of group B streptococci by counterimmunoelectrophoresis. J Clin Microbiol (1975) 2.45

Polymerase chain reaction-based restriction fragment length polymorphism analysis of a fragment of the ribosomal operon from Rochalimaea species for subtyping. J Clin Microbiol (1993) 2.41

Antimicrobial susceptibility testing of Mycobacterium fortuitum complex. Antimicrob Agents Chemother (1979) 2.40

Characterization of Klebsiella isolates from natural receiving waters and comparison with human isolates. Appl Microbiol (1974) 2.37

Contamination of commercially packaged urinary catheter kits with the pseudomonad EO-1. N Engl J Med (1970) 2.29

Rapid screening for bacteriuria by light scatter photometry (Autobac): a collaborative study. J Clin Microbiol (1981) 2.28

Quality control testing with disk antibiotic susceptibility test of Bauer-Kirby-Sherris-Turck. Am J Clin Pathol (1972) 2.23

Subgrouping of Pseudomonas cepacia by cellular fatty acid composition. J Clin Microbiol (1989) 2.23

Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J Clin Microbiol (2009) 2.20

Rochalimaea henselae causes bacillary angiomatosis and peliosis hepatis. Arch Intern Med (1992) 2.20

Relationship between superoxide dismutase and pathogenic mechanisms of Listeria monocytogenes. Infect Immun (1979) 2.15

Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J Clin Microbiol (1989) 2.15

Clinical evaluation of a lysis-centrifugation technique for the detection of septicemia. JAMA (1983) 2.12

Prevalence and characteristics of Klebsiella species: relation to association with a hospital environment. J Infect Dis (1974) 1.94

Epidemic viral hepatitis, type B, in hospital personnel. Am J Med (1974) 1.87

Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol (1987) 1.80

Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis. Am J Respir Crit Care Med (1997) 1.79

Nosocomial colonization with Klebsiella, type 26, in a neonatal intensive-care unit associated with an outbreak of sepsis, meningitis, and necrotizing enterocolitis. J Pediatr (1974) 1.78

Comparison and evaluation of carbenicillin disks in diffusion susceptibility testing. Antimicrob Agents Chemother (1974) 1.75

Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. Antimicrob Agents Chemother (1982) 1.74

Comparison of sedimentation and flotation techniques for identification of Cryptosporidium sp. oocysts in a large outbreak of human diarrhea. J Clin Microbiol (1985) 1.73

The organism causing bacillary angiomatosis, peliosis hepatis, and fever and bacteremia in immunocompromised patients. N Engl J Med (1991) 1.72

Accuracy and precision of the autobac system for rapid identification of Gram-negative bacilli: a collaborative evaluation. J Clin Microbiol (1982) 1.68

Evaluation of a lysis direct plating method for pediatric blood cultures. J Clin Microbiol (1985) 1.61

Experimental infection of young specific pathogen-free cats with Bartonella henselae. J Infect Dis (1997) 1.61

Laboratory evaluation of urinary tract infections in an ambulatory clinic. Am J Clin Pathol (1994) 1.58

Computer-assisted bacterial identification utilizing antimicrobial susceptibility profiles generated by autobac 1. J Clin Microbiol (1976) 1.56

An evaluation of the practicality of the spot-indole test for the identification of Escherichia coli in the clinical microbiology laboratory. Am J Clin Pathol (1982) 1.52

Novel approach to bacterial identification that uses the autobac system. J Clin Microbiol (1982) 1.50

Evaluation of Bactogen and Phadebact for detection of Haemophilus influenzae type b antigen in cerebrospinal fluid. J Clin Microbiol (1982) 1.50

Time-motion and cost comparison study of micro-ID, API 20E, and conventional biochemical testing in identification of Enterobacteriaceae. J Clin Microbiol (1981) 1.48

Evaluation of the Phadebact CSF test for detection of the four most common causes of bacterial meningitis. J Clin Microbiol (1983) 1.40

Septicemia and meningitis caused by Helicobacter cinaedi in a neonate. J Clin Microbiol (1993) 1.39

Klebsiella type 33 septicemia in an infant intensive care unit. J Pediatr (1972) 1.37

Viability of organisms held in the isolator blood culture system for 15 h and their rapid detection by acridine orange staining. J Clin Microbiol (1983) 1.35

Automated, rapid identification of bacteria by pattern analysis of growth inhibition profiles obtained with Autobac 1. J Clin Microbiol (1977) 1.34

Murine antibody responses distinguish Rochalimaea henselae from Rochalimaea quintana. J Clin Microbiol (1992) 1.34

Collaborative clinical evaluation of the Autobac IDX system for identification of gram-negative bacilli. J Clin Microbiol (1984) 1.30

Antimicrobial susceptibility testing of Streptococcus pneumoniae by micro-broth dilution. Antimicrob Agents Chemother (1980) 1.30

Incidence and identification of Pseudomonas fluorescens and Pseudomonas putida in the clinical laboratory. Appl Microbiol (1973) 1.30

Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories. J Clin Microbiol (1984) 1.30

Inter- and intralaboratory variability in antibiotic susceptibility tests with Pseudomonas aeruginosa and Enterobacteriaceae. J Infect Dis (1976) 1.27

Infections with Providence bacilli. A clinical and bacteriologic study. Am J Med (1971) 1.26

Carbenicillin therapy of severe Pseudomonas aeruginosa infections. J Chronic Dis (1971) 1.25

Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. Pneumococcus Study Group. J Infect Dis (1993) 1.24

Detection of Bartonella (Rochalimaea) quintana by routine acridine orange staining of broth blood cultures. J Clin Microbiol (1994) 1.23

Biochemical and antibiotic susceptibility studies of H2S-negative Citrobacter. Appl Microbiol (1974) 1.21

Review of urine microscopy for bacteriuria. JAMA (1986) 1.20

Is Clostridium difficile pathogenic in infants? J Pediatr (1982) 1.19

In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics. Antimicrob Agents Chemother (1976) 1.19

Piperacillin pharmacokinetics in subjects with chronic renal failure. Antimicrob Agents Chemother (1981) 1.18

Evaluation of a new incubation-type indole strip test. Appl Microbiol (1970) 1.18

Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin. Antimicrob Agents Chemother (1981) 1.17

Susceptibility of anaerobic bacteria to carbenicillin. Antimicrob Agents Chemother (1974) 1.17

Bioassay of antibiotics in body fluids from patients receiving cancer chemotherapeutic agents. Antimicrob Agents Chemother (1980) 1.14

Ten-minute test for differentiating between Klebsiella and Enterobacter isolates. Appl Microbiol (1970) 1.13

In vitro activity of aztreonam combined with tobramycin and gentamicin against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from patients with cystic fibrosis. Antimicrob Agents Chemother (1987) 1.13

Characterization of indole-positive Proteus mirabilis. Appl Microbiol (1972) 1.13

In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid. Antimicrob Agents Chemother (1985) 1.12

Immunocytochemical identification of Rochalimaea henselae in bacillary (epithelioid) angiomatosis, parenchymal bacillary peliosis, and persistent fever with bacteremia. Am J Surg Pathol (1992) 1.12

Antimicrobial susceptibility of Aeromonas species isolated from patients with diarrhea. Antimicrob Agents Chemother (1986) 1.11

Evidence of reproductive failure and lack of perinatal transmission of Bartonella henselae in experimentally infected cats. Vet Immunol Immunopathol (1998) 1.08

Ciprofloxacin versus tobramycin plus azlocillin in pulmonary exacerbations in adult patients with cystic fibrosis. Am J Med (1987) 1.08

In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin. Antimicrob Agents Chemother (1982) 1.07

Evaluation of a rapid bacteriuria screening instrument. Diagn Microbiol Infect Dis (1984) 1.07

Differentiation of Haemophilus spp. in Respiratory isolate cultures by an indole spot test. J Clin Microbiol (1982) 1.06

Evaluation of the Wayson variation of a methylene blue staining procedure for the detection of microorganisms in cerebrospinal fluid. J Clin Microbiol (1985) 1.05

Organisms encountered in urine cultures over a 10-year period. Appl Microbiol (1972) 1.04

Carbon monoxide production from heme compounds by bacteria. J Bacteriol (1972) 1.03

Pneumonia caused by a newly recognized pseudomonad in a child with chronic granulomatous disease. J Clin Microbiol (1990) 1.00

In-vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillin. Am J Clin Pathol (1980) 0.99

False susceptibility of enterococci to aminoglycosides with blood-enriched Mueller-Hinton agar for disk susceptibility testing. J Clin Microbiol (1985) 0.98

Fasle-positive macroscopic appearance of blood cultures in sorbitol-containing hypertonic medium. J Clin Microbiol (1979) 0.98

Recognition of Staphylococcus saprophyticus in urine cultures by screening colonies for production of phosphatase. J Clin Microbiol (1985) 0.96

Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease. Antimicrob Agents Chemother (1982) 0.96

Host factors and capsular typing of body fluid isolates in fulminant pneumococcal infections. Infect Immun (1972) 0.95

Rapid identification of swarming Proteus using the PathoTec ornithine decarboxylase test strip. J Clin Microbiol (1975) 0.95

Device for turbidity standardizing of cultures for antibiotic sensitivity testing. Appl Microbiol (1970) 0.94